10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2013 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 19, 2014) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Revenue | $ 23,113,100 | 22,603,400 | 24,286,500 |
| Cost of sales | 4,908,100 | 4,796,500 | 5,067,900 |
| Research and development | 5,531,300 | 5,278,100 | 5,020,800 |
| Marketing, selling, and administrative | 7,125,600 | 7,513,500 | 7,879,900 |
| Acquired in-process research and development | 57,100 | 0 | 388,000 |
| Asset impairment, restructuring, and other special charges | 120,600 | 281,100 | 401,400 |
| Other-net, (income) expense | 518,900 | 674,000 | (179,000) |
| Cost of sales, operating expenses, and other-net | 17,223,800 | 17,195,200 | 18,937,000 |
| Income before income taxes | 5,889,300 | 5,408,200 | 5,349,500 |
| Income taxes | 1,204,500 | 1,319,600 | 1,001,800 |
| Net income | 4,684,800 | 4,088,600 | 4,347,700 |
| Earnings per share - basic | 4.33 | 3.67 | 3.90 |
| Earnings per share - diluted | 4.32 | 3.66 | 3.90 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2013 | |||
Consolidated Statements of Comprehensive Income (Loss) | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 19, 2014) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Net income | $ 4,684,800 | 4,088,600 | 4,347,700 |
| Other comprehensive income (loss) | |||
| Foreign currency translation gains (losses) | 36,200 | 160,900 | (244,800) |
| Net unrealized gains (losses) on securities | 204,300 | 88,500 | (178,500) |
| Defined benefit pension and retiree health benefit plans | (2,592,200) | 128,600 | 1,240,200 |
| Effective portion of cash flow hedges | (123,800) | 8,700 | 44,800 |
| Other comprehensive income (loss) before income taxes | 2,708,900 | 129,500 | (1,618,700) |
| Provision for income taxes related to other comprehensive income (loss) items | (914,500) | (68,000) | 430,200 |
| Other comprehensive income (loss) | 1,794,400 | 61,500 | (1,188,500) |
| Comprehensive income | 6,479,200 | 4,150,100 | 3,159,200 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2013 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 19, 2014) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] | |||
| Net Cash Provided by Operating Activities [Abstract] | |||
| Cash Flows from Operating Activities | |||
| Net income | $ 4,684,800 | 4,088,600 | 4,347,700 |
| Adjustments to Reconcile Net Income to Cash Flows from Operating Activities: | |||
| Depreciation and amortization | 1,445,600 | 1,462,200 | 1,373,600 |
| Change in deferred income taxes | 285,900 | 126,000 | (268,500) |
| Stock-based compensation expense | 144,900 | 141,500 | 147,400 |
| Impairment charges, indefinite lived intangibles | 0 | 205,000 | 151,500 |
| Acquired in-process research and development, net of tax | 37,100 | 0 | 252,200 |
| Income related to termination of the exenatide collaboration with Amylin | (495,400) | (787,800) | 0 |
| Other operating activities, net | 25,100 | 120,500 | (17,800) |
| Changes in operating assets and liabilities, net of acquisitions | |||
| Receivables - (increase) decrease | (152,700) | 361,800 | (188,800) |
| Inventories - (increase) decrease | (286,500) | (307,900) | 203,100 |
| Other assets - (increase) decrease | 116,500 | 231,000 | 642,700 |
| Accounts payable and other liabilties-increase (decrease) | (70,300) | (336,100) | 591,400 |
| Net Cash Provided by Operating Activities | 5,735,000 | 5,304,800 | 7,234,500 |
| Net Cash Provided By (Used In) Investing Activities [Abstract] | |||
| Cash Flows from Investing Activities | |||
| Purchases of property and equipment | (1,012,100) | (905,400) | (672,000) |
| Disposals of property and equipment | 179,400 | 22,000 | 25,300 |
| Proceeds from sales and maturities of short-term investments | 3,320,100 | 2,547,500 | 1,807,900 |
| Purchases of short-term investments | (1,531,000) | (2,172,400) | (2,058,800) |
| Proceeds from sales and maturities of noncurrent investments | 11,235,000 | 4,355,700 | 2,138,500 |
| Purchases of noncurrent investments | (14,041,900) | (7,618,600) | (4,459,400) |
| Purchase of product rights | (24,100) | (138,800) | (632,900) |
| Purchases of in-process research and development | (57,100) | 0 | (388,000) |
| Cash paid for acquisitions, net of cash acquired | (43,700) | (199,300) | (307,800) |
| Net change in loan to collaboration partner | 0 | 165,000 | (165,000) |
| Proceeds from prepayment of revenue-sharing obligation | 0 | 1,212,100 | 0 |
| Other investing activities, net | (97,400) | (100,600) | (112,200) |
| Net Cash Used for Investing Activities | (2,072,800) | (2,832,800) | (4,824,400) |
| Net Cash Used in Financing Activities [Abstract] | |||
| Cash Flows from Financing Activities | |||
| Dividends paid | (2,120,700) | (2,187,400) | (2,180,100) |
| Net change in short-term borrowings | 0 | 0 | (134,100) |
| Repayments of long-term debt | (10,500) | (1,511,100) | (61,700) |
| Purchases of common stock | (1,698,100) | (721,100) | 0 |
| Other financing activities, net | 0 | 0 | 6,000 |
| Net Cash Used for Financing Activities | (3,829,300) | (4,419,600) | (2,369,900) |
| Effect of exchange rate on cash and cash equivalents | (21,500) | 43,900 | (110,900) |
| Net decrease in cash and cash equivalents | (188,600) | (1,903,700) | (70,700) |
| Cash and cash equivalents at beginning of year | 4,018,800 | 5,922,500 | |
| Cash and Cash Equivalents at End of Year | 3,830,200 | 4,018,800 | 5,922,500 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELI LILLY & CO | ||
Ticker: LLY Fiscal Year: 2013 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2013 10-K (Filed: Feb 19, 2014) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2013 | Dec 31, 2012 | |
| Assets Abstract | ||
| Current Assets | ||
| Cash and cash equivalents | $ 3,830,200 | 4,018,800 |
| Short-term investments | 1,567,100 | 1,665,500 |
| Accounts receivable, net of allowances of $100.3 (2013) and $108.5 (2012) | 3,434,400 | 3,336,300 |
| Other receivables | 588,400 | 552,000 |
| Inventories | 2,928,800 | 2,643,800 |
| Prepaid expenses and other | 755,800 | 822,300 |
| Total current assets | 13,104,700 | 13,038,700 |
| Other Assets | ||
| Investments | 7,624,900 | 6,313,900 |
| Goodwill and other intangibles, net | 4,331,100 | 4,752,700 |
| Sundry | 2,212,500 | 2,533,400 |
| Total other assets | 14,168,500 | 13,600,000 |
| Property and equipment, net | 7,975,500 | 7,760,200 |
| Total assets | 35,248,700 | 34,398,900 |
| Liabilities and Shareholders' Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturies of long-term debt | 1,012,600 | 11,900 |
| Accounts payable | 1,119,300 | 1,188,300 |
| Employee compensation | 943,900 | 940,300 |
| Sales rebates and discounts | 1,941,700 | 1,777,200 |
| Dividends payable | 523,500 | 541,400 |
| Income taxes payable | 254,400 | 143,500 |
| Deferred income taxes | 792,800 | 1,048,000 |
| Other current liabilities | 2,328,400 | 2,738,900 |
| Total current liabilities | 8,916,600 | 8,389,500 |
| Other Liabilities | ||
| Long-term debt | 4,200,300 | 5,519,400 |
| Accrued retirement benefits | 1,549,400 | 3,012,400 |
| Long-term income taxes payable | 1,078,700 | 1,334,300 |
| Other noncurrent liabilities | 1,863,000 | 1,369,400 |
| Total other liabilities | 8,691,400 | 11,235,500 |
| Shareholders' Equity | ||
| Common stock | 698,500 | 716,600 |
| Additional paid-in capital | 5,050,000 | 4,963,100 |
| Retained earnings | 16,992,400 | 16,088,200 |
| Employee benefit trust | (3,013,200) | (3,013,200) |
| Accumulated other comprehensive loss | (2,002,700) | (3,797,100) |
| Cost of common stock in treasury | (93,600) | (192,400) |
| Total Eli Lilly and Company shareholders' equity | 17,631,400 | 14,765,200 |
| Noncontrolling interests | 9,300 | 8,700 |
| Total equity | 17,640,700 | 14,773,900 |
| Total liabilities and equity | 35,248,700 | 34,398,900 |
| External Links | |
| ELI LILLY & CO (LLY) Fiscal Year 2013 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |